Endoscopic Diagnostics
The company is a medical devices company that has developed an adjunct apparatus for facilitating endoscopic diagnostic procedures. A major difficulty with current endoscopic procedures […]
The company is a medical devices company that has developed an adjunct apparatus for facilitating endoscopic diagnostic procedures. A major difficulty with current endoscopic procedures […]
The company is a medical devices company that has developed an innovative implantable apparatus for the treatment of heart failure. Heart failure is characterized by […]
The company is a medical devices company that has developed a technological platform utilizing near infrared spectroscopy to develop non-invasive diagnostic instruments for urologic conditions. […]
The company is a medical device company that has developed a cutting edge catheter-based drug delivery technology that enables the delivery of drugs to highly […]
The company is a medical devices company that has developed advanced diagnostic technology for detection of bacterial infections and their antibiotic susceptibility. The company’s novel […]
The passage of healthcare reform in March brought a wave of reimbursement-related headaches to the life science industry.
With the large Baby Boomer population reaching its senior years, the incidence of age-related vision loss in the U.S. is expected to increase.
The goal of the “2010 New York OneMedForum” is to connect private and public (microcap) medtech, biotech and health information companies with a global group of active healthcare investors.
Even before a drug or medical device reaches blockbuster status, protecting intellectual property should still be a priority.
Less than 15 percent of unsolicited inquiries to Big Pharma actually get reviewed.
How can a pharmaceutical startup grab the attention of Big Pharma?
Copyright © 2025 | WordPress Theme by MH Themes